02/04/2020

COVID-19 (Coronavirus) Updates

To Patients, Customers, Business partners and the ndd Team

I hope this finds you and your family safe and well. The Coronavirus (COVID-19) brings unexpected challenges to global trade, business and all our lives. I would like to ensure you that ndd addresses these challenges with diligence and full commitment.

ndd has installed a Pandemic Team to monitor the Coronavirus (COVID-19) disease development. We feel responsible for the safe use of our products, the safety of our customers, business partners worldwide, and of course the safety of our ndd team.

ndd Products
ndd products are safe to use. Make sure to follow the guidelines for safe lung function testing. Production of all products is up and running. We are still able to ship our products to almost all parts of the world.
Find more details here.

ndd customers and partners
All ndd staff remains at your service.  Our customers and partners can contact us as usual. Don’t hesitate to ask any specific questions about our products and services relating to the COVID-19 crisis.

Our ndd service and support is in full function. Phone support, remote service and shipment of repairs is fully available.

The ndd sales team is well equipped to provide product demonstrations and training via video conference.

Due to safety measures and travel restrictions in many areas trainings and in-services can only be performed via video conference.   

ndd team
Fortunately, no case of COVID-19 has been reported for ndd team members or their families. The safety of all team members at ndd is a top priority. Due to our well developed  IT infrastructure all ndd employees worldwide are equipped to work from home. Currently about 80% of our team works from home. ndd strictly follows the guidelines of government authorities and the general regulations that apply in the medical device industry.

All ndd members are instructed not to travel until further notice. We expect this travel restriction to remain intact for several weeks.

ndd recognizes the challenge that is presented by the Coronavirus.  We appreciate the tenacity in which the medical community has taken this on and thank you for the sacrifices you have made for the betterment of others.  Our mission of providing early diagnosis for better lung health will continue to drive everything we do.  We are committed to work with the healthcare community to assess the lung health of patients at the point of care, wherever that may be. 

Georg Harnoncourt
CEO